Paper Details

  1. Home
  2. Paper Details

Safety and tolerability of bivalent HPV vaccine: an Italian post-licensure study.

Author: AmiciziaDaniela, BechiniAngela, BoccaliniSara, BonanniPaolo, GaspariniRoberto, LaiPiero Luigi, LeviMiriam, PanattoDonatella, PatriaAntonio Giuseppe, SulajKlodiana, TiscioneEmilia

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study evaluated the safety and tolerability of the bivalent HPV vaccine Cervarix in Italy. No serious adverse events were observed. The most common side effects were pain at the injection site, fatigue, headache, and myalgia, all of which were generally mild and short-lived.
Paper Details　
Original Abstract of the Article :
One of the most important scientific discoveries of the last century was that persistent infection by some types of HPV is a precondition for the development of cervical cancer. The oncogenic types of HPV are also associated with other tumours (vaginal, vulvar and anal carcinomas, tumours of the hea...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.4161/hv.7.0.14576

データ提供：米国国立医学図書館（NLM）

HPV Vaccine: Ensuring Safety and Tolerability in a Vast Vaccination Landscape

Vaccination is a powerful tool in the fight against infectious diseases, and the development of HPV vaccines has been a major breakthrough in preventing cervical cancer. This study focuses on the safety and tolerability of the bivalent HPV vaccine Cervarix in Italy. The researchers conducted a post-licensure study, evaluating the vaccine's safety profile in a large cohort of patients. The study found that Cervarix was well-tolerated, with no serious adverse events reported. The most common side effects were mild and localized, such as pain at the injection site.

A Safe Oasis in the Desert of Vaccination

This research provides reassuring evidence of the safety and tolerability of the bivalent HPV vaccine Cervarix in Italy. The study's findings contribute to the growing body of evidence supporting the use of HPV vaccines as a safe and effective means of preventing cervical cancer.

Empowering Individuals and Communities with Confidence

The study's findings help to alleviate concerns about the safety of HPV vaccines, promoting greater confidence in vaccination programs. This increased confidence can empower individuals and communities to make informed decisions about their health and participate in vaccination programs that protect against cervical cancer.

Dr. Camel's Conclusion

This study reinforces the safety and tolerability of the bivalent HPV vaccine Cervarix, offering reassurance to healthcare providers and patients. It underscores the importance of continued surveillance and research to ensure the safety and efficacy of vaccines, ultimately contributing to a healthier and safer world.

Date :
  1. Date Completed 2011-11-30
  2. Date Revised 2019-05-16
Further Info :

Pubmed ID

21266842

DOI: Digital Object Identifier

10.4161/hv.7.0.14576

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.